On the 2023 healthcare board agenda

Six issues healthcare boards should consider for 2023

Healthcare boards can expect their oversight and corporate governance processes to be put to the test by a spectrum of ongoing and emerging challenges in the year ahead. In this paper KPMG provides insights from our latest research and interactions with business leaders across the industry to summarize six issues that healthcare boards should consider as they prepare for the year ahead. Those issues include economic risk, talent shortage, supply chain disruption, cybersecurity, diversity, equity and inclusion, and the deal environment. Read on to find more insights into how boards can assess and prepare their organizations for the challenges of 2023.

Contact us

Marc Scher

Marc Scher

Partner, National Audit Leader, Healthcare, KPMG US

+1 949-885-5402
Ash Shehata

Ash Shehata

Principal, National Sector Leader for HCLS, KPMG US

+1 513-763-2428
Board Leadership Center

Board Leadership Center

Partners, senior advisors and professionals, KPMG LLP

1-800-808-5764

Related content


KPMG Healthcare & Life Sciences Institute

Register to receive timely insights

Register to receive timely insights

About Healthcare & Life Sciences at KPMG

Our practice

Learn more


Our capabilities

Learn more


Meet our team

Learn more